More Than a Voice: How Patient Organizations Are Driving Industry R&D from the Start

Meaningful access to innovation begins long before a therapy reaches the pharmacy. For millions of people living with complex chronic conditions, rare diseases, and underserved diagnoses, the gap between a promising treatment and an accessible one is shaped as much by who is at the R&D bench as by the science itself. In this session panelists will examine how partnerships linking patient organizations and industry are emerging as powerful levers for more equitable and efficient biomedical innovation. The panel of patient-organization executives will explain how patient organizations are shaping development priorities, clinical trial design, and access strategies from the start.